Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
|ClinicalTrials.gov Identifier: NCT00583128|
Recruitment Status : Completed
First Posted : December 31, 2007
Last Update Posted : June 18, 2014
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||May 2010|
|Actual Study Completion Date :||June 2010|
|Certification/Extension First Submitted :||July 26, 2013|
Publications of Results:
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. Review.
Schuster MM. Defining and diagnosing irritable bowel syndrome. Am J Manag Care. 2001 Jul;7(8 Suppl):S246-51. Review.
Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 2006 Aug;55(8):1095-103. Epub 2006 Jan 9.